PMC:7253482 / 20422-20747 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T71992 1-7 NN denotes RM20A3
T28802 8-21 JJ denotes base-specific
T65942 22-28 NN denotes Fabs51
T27171 31-40 JJ denotes Disparate
T82701 41-50 NN denotes shielding
T84269 51-61 NNS denotes efficacies
T39330 62-64 IN denotes of
T82468 65-70 JJ denotes viral
T81349 71-84 NN denotes glycosylation
T55443 85-90 JJ denotes Viral
T49065 91-99 NN denotes envelope
T84653 100-108 NNS denotes proteins
T43155 109-112 VBP denotes are
T38543 113-125 VBN denotes glycosylated
T78070 126-128 TO denotes to
T10289 129-136 VBG denotes varying
T40134 137-144 NNS denotes degrees
T67415 144-145 -COMMA- denotes ,
T91973 146-149 CC denotes but
T56277 150-159 VBG denotes depending
T67259 160-162 IN denotes on
T24257 163-168 PRP-DOLLAR- denotes their
T41537 169-176 JJ denotes overall
T90997 177-181 NN denotes mass
T80023 181-182 -COMMA- denotes ,
T58957 183-190 NN denotes surface
T24905 191-195 NN denotes area
T39391 195-196 -COMMA- denotes ,
T28342 197-200 CC denotes and
T95089 201-207 NN denotes volume
T63529 207-208 -COMMA- denotes ,
T2361 209-212 DT denotes the
T67520 213-220 JJ denotes overall
T74143 221-228 NN denotes density
T41564 229-231 IN denotes of
T83144 232-238 NN denotes glycan
T18180 239-248 NN denotes shielding
T4164 249-252 MD denotes may
T65417 253-259 VB denotes differ
T71938 260-273 RB denotes significantly
T57335 275-278 IN denotes For
T68440 279-286 NN denotes example
T98634 286-287 -COMMA- denotes ,
T80942 288-292 CC denotes both
T39961 293-297 NN denotes LASV
T61867 298-301 NN denotes GPC
T97427 302-305 CC denotes and
T69629 306-317 NN denotes coronavirus
T13147 318-319 NN denotes S
R10660 T65942 T71992 arg1Of Fabs51,RM20A3
R12128 T74143 T41564 arg1Of density,of
R17171 T38543 T43155 arg2Of glycosylated,are
R22100 T18180 T83144 arg1Of shielding,glycan
R28079 T65417 T4164 arg2Of differ,may
R31934 T28342 T24257 arg1Of and,their
R33832 T24905 T58957 arg1Of area,surface
R34126 T61867 T97427 arg1Of GPC,and
R35471 T65942 T28802 arg1Of Fabs51,base-specific
R37591 T67259 T56277 arg2Of on,depending
R39386 T65417 T91973 arg2Of differ,but
R40876 T74143 T67520 arg1Of density,overall
R47214 T97427 T80942 arg1Of and,both
R47307 T91973 T67415 arg1Of but,","
R49480 T74143 T65417 arg1Of density,differ
R49906 T61867 T39961 arg1Of GPC,LASV
R54906 T84269 T27171 arg1Of efficacies,Disparate
R55540 T40134 T78070 arg2Of degrees,to
R5643 T90997 T80023 arg1Of mass,","
R57079 T90997 T41537 arg1Of mass,overall
R59653 T84269 T39330 arg1Of efficacies,of
R61108 T68440 T57335 arg2Of example,For
R62725 T84653 T55443 arg1Of proteins,Viral
R65728 T84653 T43155 arg1Of proteins,are
R67091 T80023 T28342 arg1Of ",",and
R72983 T95089 T28342 arg2Of volume,and
R74094 T74143 T2361 arg1Of density,the
R76809 T38543 T91973 arg1Of glycosylated,but
R77082 T65417 T71938 arg1Of differ,significantly
R77574 T65417 T56277 arg1Of differ,depending
R78096 T18180 T41564 arg2Of shielding,of
R79509 T84653 T38543 arg2Of proteins,glycosylated
R80018 T81349 T82468 arg1Of glycosylation,viral
R80559 T40134 T10289 arg1Of degrees,varying
R84776 T38543 T78070 arg1Of glycosylated,to
R8931 T74143 T4164 arg1Of density,may
R90521 T84653 T49065 arg1Of proteins,envelope
R91640 T84269 T82701 arg1Of efficacies,shielding
R91669 T65417 T63529 arg1Of differ,","
R92515 T24905 T80023 arg2Of area,","
R98141 T28342 T39391 arg1Of and,","
R98364 T81349 T39330 arg2Of glycosylation,of
R98678 T28342 T67259 arg2Of and,on